Health Care Resource Utilization and Costs Among Medicare Beneficiaries Newly Diagnosed With Peripheral T-cell Lymphoma: A Retrospective Claims Analysis

This was a prescription claims-based analysis of the real-world treatment patterns, health care resource utilization, costs and survival outcomes in 2551 Medicare beneficiaries newly diagnosed with PTCL from 2011-2017. Data indicate significant use of resources prior to and following diagnosis, with no evident standard of care; survival outcomes at the time of analysis remained poor.

Source: Clinical Lymphoma, Myeloma and Leukemia - July 20, 2020 Category: Hematology Authors: Anne Shah, Allison Petrilla, Mayvis Rebeira, Joseph Feliciano, Julie Lisano, Thomas W. LeBlanc Tags: Original Study Source Type: research